Maykl C. Snabes, MD, PhD, vice president of the clinical development of the Pharmaceuticalses BioSante, will present the review of the key analysis in LibiGel phenomenon (the jell testosterone) programme in Endocrine Society 90-e Annual Meeting in San Francisco in the Centre Moscone in Sunday, 15 June, 2008. The Announcement named ” Cardiovascular And Breast Safe Study Libigel In Woman with Sexual pharmacy pill Disorder of the Desire Hypoactive (HSDD): Project of the Analysis And Descriptions of the Endpoints,” - co-authored investigator and counselor in University Connecticut School Medicine, Consultants of the Berry, and M.D. The Cancerous Centre Anderson.

The Conference of the news will is organized inn Sunday, 15 June, 2008, For the time of which reporters invited to mark the announcement and discuss LibiGel and described interpretation by Dr. Snabes.

BioSante CONDUCTS the safe analysis, in post-woman menopausal with inactive sexual hale condition disorder of the desire (HSDD), on beg USA. Food and Administration Medicine. The Request - inn agreement with call to more safe given from Endocrine Society, medical society to professions, that is focused in endocrine and metabolous disease.

Dr. Snabes noted grandness this preceding installing the analysis. “This clinical test to study the long-term effects testosterone in post-woman menopausal, can have existence at one of to begin big, cardiovascular operated events, studies pre- approvals whirr undertaken in the absence of clear safe communication.”

BioSante EXPECTS that enrolled and is Tried aproximately three thousandth posts-womans menopausal between age fifty and cardinal and, which has at least once one cardiovascular divisor of the risk. The pharmacy online Primary safe result for this Assay - an result of the processing in incidence heartily at any rate, including cardiovascular bound death, heart attack, and blow. Incidence invasive breast cancer is a primary safe endpoint co-, and investigators will also look the favourable breast breast cancer of the masses and non-invasives. The Patients will are evaluated In favor of hairiness, acne, and speech pattern or reactions of the skin, as well as royal line testosterone be justified during each visit of the analysis.

HSDD is CHARACTERIZED low libido and the general defect of the interest in sex. If safe endpoints counter and approves the medicine, LibiGel will befit first authorized processing specified for HSDD in menopausal woman. BioSante EXPECTS the approval never-failing time during 2010 or 2011.

The Feminine sexual dysfunction can arise out of many reasons, including problems relations, consume the pharmaceuticalses of the prescription, illness, or chemical imbalances. HSDD ADDRESSES successfully and successfully with testosterone for many years though and to rendezvous not approved for this use. In terminated analysis Phase II LibiGel show excellent safe keeping and efficiency. However, recently became interested cardiovascular and cancerous risk Followed by to or for Destined broad class medicine, amongst him potential therapy for FSD. The satisfactory analysis of the Phase III be witting to confirm long-term safety LibiGel’s.

The Operated analysis studies the effect LibiGel in post-woman drugstore online menopausal inn dose 300 micrograms per diem over twelve months. BioSante be SPECIFICALLY focused in heartily event and incidence breast cancer. After twelve plans of the months BioSante to apply for put one’s imprimatur on through New Application Medicine (NDA). requires BioSante to follow the group of the analysis during supplementary fourty-eight months, after subservience NDA and potential approval to compare mate the warmhearted event and breast cancer between alliance of the processing and corresponding to group of the womans, who get the gel

LibiGel - a gel 1% testosterone that woman enclose for the reon that soon as day, inn their upper lever. Measured pea volume helium carries through skin quickly, from where he delivers the firm dose testosterone on blood.

Though testosterone thought-out as manly hormone, he is also discovered in woman on of the same rank approaching with they’re age. The Researchers believe that testosterone will justify, what fall with increasing of the age, can control the feminine sexual drawing. For instance, woman in her have about blood testosterone as domestic inn hits twenty.

Incidence HSDD also increases from that time age and after determined surgical procedures. Aproximately 14% premenopausal womans prep age twenty and fourty-nine registered HSDD, inn contrast with 26% womans, online pharmacy tablet who surgical have deleted their ovaries. Similarly, incidence HSDD grows before 9% for “naturally” menopausal womans. LibiGel is INTENDED to restore the level testosterone in post-womans menopausal on level, which are considered normal two support sound libido.

The Results of the Analysis, which carry the preceding safe information finally must lie to put the safe enxiety for processing testosterone in woman and lead to approval of the first safe, efficient processing was specifically indicated appropriate throughout HSDD in menopausal sweetie.